Agile Therapeutics SG&A Expense (Quarterly) Analysis

Agile Therapeutics Inc (AGRX)

0.3685 +0.01 (+2.08%) USD | OTCM | Jun 03, 15:55

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	6.298M
December 31, 2023	5.421M
September 30, 2023	7.48M
June 30, 2023	7.619M
March 31, 2023	7.755M
December 31, 2022	8.869M
September 30, 2022	8.375M
June 30, 2022	10.44M
March 31, 2022	14.55M
December 31, 2021	16.49M
September 30, 2021	12.76M
June 30, 2021	15.83M
March 31, 2021	13.05M
December 31, 2020	14.20M
September 30, 2020	10.99M
June 30, 2020	6.378M
March 31, 2020	4.453M
December 31, 2019	3.268M
September 30, 2019	2.138M
June 30, 2019	1.768M
March 31, 2019	1.826M
December 31, 2018	1.566M
September 30, 2018	1.767M

Date	Value
June 30, 2018	2.318M
March 31, 2018	3.086M
December 31, 2017	3.253M
September 30, 2017	3.526M
June 30, 2017	3.198M
March 31, 2017	2.405M
December 31, 2016	2.295M
September 30, 2016	2.18M
June 30, 2016	2.264M
March 31, 2016	2.053M
December 31, 2015	2.252M
September 30, 2015	1.803M
June 30, 2015	1.813M
March 31, 2015	1.599M
December 31, 2014	1.546M
September 30, 2014	1.446M
June 30, 2014	1.104M
March 31, 2014	1.053M
December 31, 2013	0.6705M
September 30, 2013	0.9235M
June 30, 2013	0.8233M
March 31, 2013	1.157M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.768M

Minimum

Jun 2019

16.49M

Maximum

Dec 2021

8.906M

Average

8.065M

Median

SG&A Expense (Quarterly) Benchmarks